Baldev Vasir

2.4k citations

42 papers · 1.7k indexed · h-index 20

Impact in

Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Hematology top 2%
- Multiple Myeloma Research and Treatments

Papers in

Immunology 30
- Immunotherapy and Immune Responses 23
- Immune Cell Function and Interaction 10
- T-cell and B-cell Immunology 9
Hematology 15
- Multiple Myeloma Research and Treatments 9

Co-authors: Donald Küfe David Avigan Jacalyn Rosenblatt Zekui Wu Gordon C. Weir Susan Bonner‐Weir Robin Joyce James D. Levine
Journals: Blood (12 papers)Journal of Clinical Oncology (5 papers)Journal of Immunotherapy (4 papers)Biology of Blood and Marrow Transplantation (3 papers)Transplantation (3 papers)
Partner nations: United States Israel United Kingdom

In The Last Decade

Baldev Vasir

42 papers receiving 1.7k citations

Peers

Countries citing papers authored by Baldev Vasir

Since Specialization

Citations

This map shows the geographic impact of Baldev Vasir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baldev Vasir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baldev Vasir more than expected).

Fields of papers citing papers by Baldev Vasir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baldev Vasir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baldev Vasir. The network helps show where Baldev Vasir may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Baldev Vasir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Baldev Vasir Line = papers co-authored together Baldev Vasir links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells Cancer Research ·Dina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito, Heidi Mills, Li Yin, Hasan Rajabi, Baldev Vasir, Turner Kufe, Katarina Luptakova, Jon Arnason, Caterina Nardella, James D. Levine, Robin Joyce, Ilene Galinsky, Yoram Reiter, Richard M. Stone, Pier Paolo Pandolfi, Donald Küfe, David Avigan	2013	41
2	Co-Expression Of The MUC1 Oncoprotein and CD34 On Primary Myeloma Bone Marrow Cells Identifies a Population With Myeloma Initiating Potential Blood ·Katarina Luptakova, Jacalyn Rosenblatt, Dina Stroopinsky, Heidi Mills, Jana Jakubı́ková, John G. Clohessy, S Qulmatova, Baldev Vasir, Hasan Rajabi, Maxwell Coll, Kristen Palmer, Jon Arnason, Jeffrey I. Zwicker, Robin Joyce, Ayad Hamdan, James D. Levine, Constantine S. Mitsiades, Kenneth C. Anderson, Donald Küfe, David Avigan	2013	1
3	STAT3 Inhibition Promotes Potent Th1 Responses By Down Regulating Pdl-1 Expression On Tumor Cells Blood ·Baldev Vasir, Hasan Rajabi, Heidi Mills, Jacalyn Rosenblatt, Dina Stroopinsky, Katarina Luptakova, Maxwell Coll, Mohammad Tuqan, Donald Küfe, David Avigan	2013	1
4	Induction of Antitumor Immunity Ex Vivo Using Dendritic Cells Transduced With Fowl Pox Vector Expressing MUC1, CEA, and a Triad of Costimulatory Molecules (rF-PANVAC) Journal of Immunotherapy ·Baldev Vasir, Corrine Zarwan, Rehan Ahmad, Keith Crawford, Beom-Hun Song, Ken‐ichi Matsuoka, Jacalyn Rosenblatt, Zekui Wu, Heidi Mills, Donald Küfe, David Avigan	2012	8
5	Lenalidomide enhances anti-myeloma cellular immunity Cancer Immunology Immunotherapy ·Katarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Dina Stroopinsky, Turner Kufe, Baldev Vasir, Jon Arnason, D Brutin, Jeffrey I. Zwicker, Robin Joyce, James D. Levine, Kenneth C. Anderson, Donald Küfe, David Avigan	2012	132
6	PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine Journal of Immunotherapy ·Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Baldev Vasir, Dimitrios Tzachanis, James D. Levine, Robin Joyce, Kerry Wellenstein, Tianyuan Jiang, Michael Schickler, Rinat Rotem‐Yehudar, Donald Küfe, David Avigan	2011	237
7	Immunomodulatory effects of vitamin D: implications for GVHD Bone Marrow Transplantation ·Jacalyn Rosenblatt, Jenny Fernanda Enríquez Chugá, Rehan Ahmad, B. Bouker Bakioui, Baldev Vasir, Kristen E. Stevenson, Corrine Zarwan, Tianyuan Jiang, Brett Glotzbecker, Heidi Mills, Robin Joyce, James D. Levine, D Brutin, Vassiliki A. Boussiotis, Donald Küfe, David Avigan	2010	33
8	Survival of Human Multiple Myeloma Cells Is Dependent on MUC1 C-Terminal Transmembrane Subunit Oncoprotein Function Molecular Pharmacology ·Li Yin, Rehan Ahmad, Michio Kosugi, Turner Kufe, Baldev Vasir, David Avigan, Surender Kharbanda, Donald Küfe	2010	26
9	Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28 Journal of Immunotherapy ·Jacalyn Rosenblatt, Zekui Wu, Baldev Vasir, Corrine Zarwan, Richard Stone, Heidi Mills, Thea M. Friedman, Panagiotis A. Konstantinopoulos, Dimitrios Spentzos, Musie Ghebremichael, Kristen E. Stevenson, Donna Neuberg, James D. Levine, Robin Joyce, Dimitrios Tzachanis, Vassiliki A. Boussiotis, Donald Küfe, David Avigan	2010	23
10	Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells Cancer Research ·Deepak Raina, Rehan Ahmad, Maya Datt Joshi, Yin Li, Zekui Wu, Takeshi Kawano, Baldev Vasir, David Avigan, Surender Kharbanda, Donald Küfe	2009	125
11	Fusions of Dendritic Cells with Breast Carcinoma Stimulate the Expansion of Regulatory T Cells while Concomitant Exposure to IL-12, CpG Oligodeoxynucleotides, and Anti-CD3/CD28 Promotes the Expansion of Activated Tumor Reactive Cells The Journal of Immunology ·Baldev Vasir, Zekui Wu, Keith Crawford, Jacalyn Rosenblatt, Corrine Zarwan, Jenny Fernanda Enríquez Chugá, Donald Küfe, David Avigan	2008	41
12	Phase I/II Study of Vaccination With Electrofused Allogeneic Dendritic Cells/Autologous Tumor-derived Cells in Patients With Stage IV Renal Cell Carcinoma Journal of Immunotherapy ·David Avigan, Baldev Vasir, Daniel J. George, William Oh, Michael B. Atkins, David F. McDermott, Philip W. Kantoff, Robert A. Figlin, Michael J. Vasconcelles, Yuanxin Xu, Donald Küfe, Ronald M. Bukowski	2007	86
13	Vaccination with DC/Multiple Myeloma Fusions in Conjunction with Stem Cell Transplantation. Blood ·David Avigan, Jacalyn Rosenblatt, Baldev Vasir, Zekui Wu, Jenny Fernanda Enríquez Chugá, Antica Cikojević, Lynne Uhl, Jeanne Blakeslee, Kenneth B. Miller, James D. Levine, Robin Joyce, Themo Voswinckel, Dilani Dombagoda, Paul G. Richardson, Kenneth C. Anderson, Nikhil C. Munshi, Alberto Suarez Calderón	2007	1
14	Dendritic Cells Induce MUC1 Expression and Polarization on Human T Cells by an IL-7-Dependent Mechanism The Journal of Immunology ·Baldev Vasir, David Avigan, Zekui Wu, Keith Crawford, Terry Cheng, Jian Ren, Donald Küfe	2005	26
15	Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation British Journal of Haematology ·Baldev Vasir, Virginia F. Borges, Zekui Wu, Paul David Lonquich, Jacalyn Rosenblatt, Masaki Irie, Kenneth C. Anderson, Donald Küfe, David Avigan	2005	47
16	Interim safety and efficacy results from a phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma Journal of Clinical Oncology ·David Avigan, D. George, Philip W. Kantoff, Robert A. Figlin, D Kufe, Thomas Olencki, Michael J. Vasconcelles, Baldev Vasir, Yaomin Xu, Ronald M. Bukowski	2004	3
17	Interim safety and efficacy results from a phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma Journal of Clinical Oncology ·David Avigan, Daniel J. George, Philip W. Kantoff, Robert A. Figlin, D Kufe, Thomas Olencki, Michael J. Vasconcelles, Baldev Vasir, Yaomin Xu, Ronald M. Bukowski	2004	10
18	CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation Blood ·Keith Crawford, Thayana Abreu Viza Figueiredo, Jaydeep Vijay Inamdar, Julio Casillas-Ledesma, Н В Парин, Ellen Triantafellow, Zhigang Wang, Baldev Vasir, Charles E. Larsen, Dana Gabuzda, Ellis L. Reinherz, Chester A. Alper	2003	29
19	GENE EXPRESSION OF VEGF AND ITS RECEPTORS Flk-1/KDR AND Flt-1 IN CULTURED AND TRANSPLANTED RAT ISLETS1 Transplantation ·Baldev Vasir, Jean‐Christophe Jonas, Garry M. Steil, Jennifer Hollister‐Lock, Wendy Hasenkamp, Arun Sharma, Susan Bonner‐Weir, Gordon C. Weir	2001	91
20	Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-α, TGF-β, bFGF and Vimentin) in cultured and transplanted rat islets Diabetologia ·Baldev Vasir, 理江阿波, Gang Xu, Arun Sharma, Susan Bonner‐Weir, Gordon C. Weir	2000	73

About Baldev Vasir

Baldev Vasir is a scholar working on Immunology, Hematology, Virology, Oncology and Biotechnology, having authored 42 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), Immune Cell Function and Interaction (10 papers), Glycosylation and Glycoproteins Research (9 papers), Multiple Myeloma Research and Treatments (9 papers), T-cell and B-cell Immunology (9 papers), CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and vaccines and immunoinformatics approaches (5 papers). The work is most often cited by research in Immunology (931 citations), Hematology (363 citations), Oncology (762 citations), Virology (95 citations) and Molecular Biology (735 citations). Baldev Vasir has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Donald Küfe, David Avigan, Jacalyn Rosenblatt, Zekui Wu, Gordon C. Weir, Susan Bonner‐Weir, Robin Joyce, James D. Levine, Heidi Mills and Brett Glotzbecker. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Immunotherapy, Biology of Blood and Marrow Transplantation and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact